BioSpace News Archive

Gracell Biotechnologies Inc. today announced that the management team will participate in BTIG 2022 Hybrid Biotechnology Conference in August 2022.

Simulations Plus , Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the presentation of five scientific posters by Simulations Plus scientists at the Population Approach Group in Europe (PAGE) conference held in Ljubljana, Slovenia.

Evofem Biosciences, Inc., announced a series of industry awards and recognition for the company’s direct-to-consumer advertising campaign, House Rules.

Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the company’s management team will be participating in one-on-one meetings at the upcoming BTIG Biotechnology Conference, which is taking place both virtually and at the St. Regis New York Hotel in New York City, August 8-9, 2022.

Ecolab Second Quarter Reported Diluted EPS $1.08; Adjusted Diluted EPS $1.10; Expect Improved Second Half 2022 Performance.

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that Pat Miles, Chairman and Chief Executive Officer, and Todd Koning, Chief Financial Officer, will participate in the following investor events:

City of Hope, one of the largest cancer research and treatment organizations in the United States, was recognized as the seventh “Best Hospital” for cancer in the nation according to U.S. News & World Report’s 2022-23 Best Hospitals: Specialty Ranking.

Forecast to 2030,’ thoroughly examines the Tonsillitis industry to provide essential data & information for the targeted readers.

The report consists of quantitative and qualitative research on the market performed by our market experts.

Forecast to 2030,’ thoroughly examines the Keloid industry to provide essential data & information for the targeted readers.